| Literature DB >> 29527152 |
Shu-Hong Jia1, Kai Li1, Wen Su1, Shu-Hua Li1, Hai-Bo Chen1.
Abstract
Objective: Patients with Parkinson's disease have prospective memory impairments. However, little is known about distinct phases of prospective memory in these patients. This study was designed to elucidate the specific phase(s) of prospective memory that are impaired in patients with Parkinson's disease.Entities:
Keywords: Parkinson's disease; cognitive impairment; executive function; neuropsychological assessment; prospective memory
Year: 2018 PMID: 29527152 PMCID: PMC5829067 DOI: 10.3389/fnins.2018.00098
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Figure 1The flow chart of our procedure.
Clinical characteristics of PD patients and healthy controls.
| Age | 66.42 ± 7.80 | 67.63 ± 8.14 | 0.566 |
| Gender (male/female) | 20/11 | 15/12 | 0.487 |
| Education (years) | 13.16 ± 3.14 | 13.30 ± 3.09 | 0.870 |
| Disease duration (years) | 5.32 ± 4.07 | ||
| Amantadine | 14 (45.2) | ||
| Levodopa | 24 (77.4) | ||
| Receptor agonist | 14 (45.2) | ||
| Levodopa equivalent daily dose (mg) | 457 ± 288 | ||
| UPDRS | 41.74 ± 15.64 | ||
| H-Y stage | 2.29 ± 0.60 | ||
| Side of onset (left/right) | 14/17 | ||
| MMSE | 28.55 ± 1.29 | 28.89 ± 0.93 | 0.260 |
| HRSD | 6.10 ± 2.0 | 1.89 ± 1.45 | <0.001 |
| DST | 12.19 ± 2.12 | 13.41 ± 1.91 | 0.027 |
| Working memory | 12.06 ± 5.09 | 5.15 ± 3.36 | <0.001 |
| Stroop test | 9.10 ± 4.61 | 2.15 ± 2.43 | <0.001 |
DST, Digit span test; HC, healthy controls; H-Y stage, Hoehn and Yahr Stage; MMSE, Mini-Mental State Examination; HRSD, Hamilton Rating Scale for Depression; PD, Parkinson's disease; UPDRS: unified Parkinson's disease rating scale.
Regression analysis results for PM performances of PD patients and healthy controls.
| Intention formation | 8.16 ± 2.62 | 13.59 ± 3.00 | 0.701 | 3.952–6.911 | <0.001 |
| Adjusted | 0.767 | 3.765–8.124 | <0.001 | ||
| Retention right, n (%) | 25 (80.6) | 24 (88.9) | 0.521 | 0.117–2.322 | 0.392 |
| Adjusted | 5.571 | 0.416–74.546 | 0.194 | ||
| Initiation on time, n (%) | 11 (35.5) | 14 (51.9) | 0.511 | 0.178–1.465 | 0.212 |
| Adjusted | 1.905 | 0.274–13.261 | 0.515 | ||
| Fidelity right, n (%) | 27 (87.1) | 25 (92.6) | 0.540 | 0.091–3.210 | 0.498 |
| Adjusted | 3.803 | 0.152–95.370 | 0.417 | ||
| Execution score | 177.74 ± 37.85 | 203.63 ± 26.87 | 0.368 | 8.375–43.400 | 0.004 |
| Adjusted (model 1) | 0.013 | −21.450–23.348 | 0.933 | ||
| Adjusted (model 2) | 0.049 | −23.170–30.011 | 0.797 |
HC, healthy controls
Adjusted for age, sex, and the scores of DST, working memory and Stroop test.
Adjusted for age, sex, and the scores of DST, working memory, Stroop test, intention formation, intention retention and fidelity.
Correlation coefficients between clinical and demographical characteristics and PM performance in distinct phases.
| Age | −0.354 | −0.064 | 0.163 | 0.194 | −0.238 |
| Disease duration | 0.308 | 0.234 | |||
| H-Y stage | 0.004 | −0.208 | 0.096 | ||
| Education | −0.129 | −0.009 | 0.145 | 0.253 | 0.221 |
| HRSD | 0.17 | −0.183 | 0.227 | −0.354 | −0.285 |
p < 0.001;
p < 0.01;
p < 0.05.
H-Y stage, Hoehn and Yahr Stage; HRSD, Hamilton Rating Scale for Depression. Values in bold indicate a statistically significant correlation (p < 0.05).